SARAH COVINGTON: Open Payments
NPI 1679937403 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 75 payments from 30 companies in 2025. Trend: 2023 $456 · 2024 $2,218 · 2025 $1,881
Food & beverage: $1,881
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $335 |
| E.R. Squibb & Sons, L.L.C. | 7 | $299 |
| AstraZeneca Pharmaceuticals LP | 11 | $218 |
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| PFIZER INC. | 8 | $141 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Incyte Corporation | 3 | $62 |
| Exelixis Inc. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
Products named: REBLOZYL, RYBREVANT, ENHERTU, ERLEADA, OPDIVO, PLUVICTO, KEYTRUDA, TECVAYLI.
Industry payments across NC — which companies pay providers there.
